Medicare AdvantageCoverageMedium impact
MA08.004z, Coagulation Factors
Independence Blue Cross·Hematology, Oncology, Internal Medicine +1 more·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA08.004z for Coagulation Factors has been updated with changes to medical necessity criteria, medical coding, and general guidelines. This affects how coagulation factor treatments are covered and billed under Medicare Advantage plans.
Action Required
Before January 1, 2026: Billing team must review updated policy MA08.004z at the source URL to understand new medical necessity criteria and coding changes for coagulation factors. Update billing software and encounter forms based on new requirements. Ensure providers are aware of revised documentation requirements for coagulation factor treatments.